000 04557naa a22005657i 4500
001 UMUN-OA-20261005-PH-021
003 local
005 20261005174912.0
006 m o d
007 cr||||||||||||
008 261005s2020 xx o u000 0 eng d
024 7 _a10.1136/bmjopen-2019-034082
_2doi
035 _a(local)EuropePMC:PMC7371213
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aMelissa Mialon
_eauthor.
245 1 0 _aMechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. /
_cMelissa Mialon; Stefanie Vandevijvere; Angela Carriedo-Lutzenkirchen [and others].
264 1 _a[Place of publication not identified] :
_bBMJ Publishing Group,
_c2020.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aObjective We identified mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, as well as examples of where these mechanisms have been adopted from across the globe. Design We conducted a scoping review. We conducted searches in five databases on 4 June 2019. Twenty-eight relevant institutions and networks were contacted to identify additional mechanisms and examples. In addition, we identified mechanisms and examples from our collective experience working on the influence of corporations on public health policy, research and practice. Setting We identified mechanisms at the national, regional and global levels. Results Thirty-one documents were included in our review. Eight were peer-reviewed scientific articles. Nine discussed mechanisms to address and/or manage the influence of different types of industries; while other documents targeted specific industries. In total, we identified 49 mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, and 43 of these were adopted at the national, regional or global level. We identified four main types of mechanisms: transparency; management of interactions with industry and of conflicts of interest; identification, monitoring and education about the practices of corporations and associated risks to public health; prohibition of interactions with industry. Mechanisms for governments (n=17) and academia (n=13) were most frequently identified, with fewer for the media and civil society. Conclusions We identified several mechanisms that could help address and/or manage the negative influence of corporations on public health policy, research and practice. If adopted and evaluated more widely, many of the mechanisms described in this manuscript could contribute to efforts to prevent and control non-communicable diseases. Trial registration details The protocol was registered with the Open Science Framework on 27 May 2019 (https://osf.io/xc2vp).
540 _aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by-nc/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Public Health.
650 4 _aPublic Policy
650 4 _aCorporate Political Activity
650 4 _aCommercial Determinants Of Health
653 _aB. Sc. Public Health
653 _aUMUN open access collection
653 _ahealth policy
655 4 _aReview articles.
700 0 _aStefanie Vandevijvere
_eauthor.
700 0 _aAngela Carriedo-Lutzenkirchen
_eauthor.
700 0 _aLisa Bero
_eauthor.
700 0 _aFabio Gomes
_eauthor.
700 0 _aMark Petticrew
_eauthor.
700 0 _aMartin McKee
_eauthor.
700 0 _aDavid Stuckler
_eauthor.
700 0 _aGary Sacks
_eauthor.
773 0 _tBMJ open
_gVol. 10, no. 7, (2020), pages/article e034082
_x2044-6055
856 4 0 _uhttps://europepmc.org/articles/PMC7371213
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC7371213
_qlocal
942 _n0
999 _c1293
_d1293